Maison, Nicole; Omony, Jimmy; Illi, Sabina; Thiele, Dominik; Skevaki, Chrysanthi; Dittrich, Anna-Maria; Bahmer, Thomas; Rabe, Klaus Friedrich; Weckmann, Markus; Happle, Christine; Schaub, Bianca; Meier, Meike; Foth, Svenja; Rietschel, Ernst; Renz, Harald; Hansen, Gesine; Kopp, Matthias Volkmar; von Mutius, Erika; Grychtol, Ruth (2022). T-high asthma phenotypes across life span. The European respiratory journal, 60(3) European Respiratory Society 10.1183/13993003.02288-2021
|
Text
13993003.02288-2021.full.pdf - Accepted Version Available under License Publisher holds Copyright. Download (2MB) | Preview |
RATIONALE
In adults, personalised asthma treatment targets patients with T2-high and eosinophilic asthma phenotypes. It is unclear whether such classification is achievable in children.
OBJECTIVES
To define T2-high asthma with easily accessible biomarkers and compare resulting phenotypes across all ages.
METHODS
In the multicenter clinical ALL Age Asthma Cohort (ALLIANCE), 1125 participants (n=776 asthmatics, n=349 controls) were recruited and followed for 2 years (1 year in adults). Extensive clinical characterisation (questionnaires, blood differential count, allergy testing, lung function and sputum induction (in adults) was performed at baseline and follow-ups. Interleukin (IL)-4, IL-5 and IL-13 were measured after stimulation of whole blood with LPS or anti-CD3/CD28.
MEASUREMENTS AND MAIN RESULTS
Based on blood eosinophil counts and allergen-specific serum IgE antibodies (sIgE), patients were categorised into four mutually exclusive phenotypes: "Atopy-only", "Eosinophils-only", "T2-high" (eosinophilia+atopy) and "T2-low" (neither eosinophilia nor atopy). The T2-high phenotype was found across all ages, even in very young children in whom it persisted to a large degree even after 2 years of follow-up. T2-high asthma in adults was associated with childhood onset suggesting early origins of this asthma phenotype. In both children and adults, the T2-high phenotype was characterised by excessive production of specific IgE to allergens (p<0.0001) and, from school age onwards, by increased production of IL-5 after anti-CD3/CD28 stimulation of whole blood.
CONCLUSIONS
Using easily accessible biomarkers, patients with T2-high asthma can be identified across all ages delineating a distinct phenotype. These patients may benefit from therapy with biologicals even at younger age.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine |
UniBE Contributor: |
Kopp, Matthias Volkmar |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1399-3003 |
Publisher: |
European Respiratory Society |
Language: |
English |
Submitter: |
Anette van Dorland |
Date Deposited: |
01 Mar 2022 09:05 |
Last Modified: |
26 Feb 2023 00:25 |
Publisher DOI: |
10.1183/13993003.02288-2021 |
PubMed ID: |
35210326 |
BORIS DOI: |
10.48350/166092 |
URI: |
https://boris.unibe.ch/id/eprint/166092 |